| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Buprenorphine+Norbuprenorphine | LP34573-3 |
| PROPERTY | PrThr | LP217195-9 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Saliva | LP7565-7 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | Confirm | LP6197-0 |
| AnswerList | Pos|Neg | LL360-9 |
| parent | Buprenorphine+Norbuprenorphine | Saliva | Drug toxicology | LP389834-5 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both |
| LONG_COMMON_NAME | en-US | Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
| LONG_COMMON_NAME | en-US | Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
| SHORTNAME | en-US | Buprenorphine+Nor Sal Ql Cfm |
| ConsumerName | en-US | Buprenorphine+Norbuprenorphine, Saliva |
| LONG_COMMON_NAME | fr-FR | Buprénorphine+norbuprénorphine [Présence/Seuil] Salive ; Qualitatif ; Confirmation |
| LONG_COMMON_NAME | nl-NL | Buprenorfine + norbuprenorfine [aanwezigheid] in speeksel d.m.v. bevestiging |
| LONG_COMMON_NAME | es-MX | Buprenorfina + Norbuprenorfina: Saliva : Punto temporal: Presencia o umbral: Ordinal: Confirmar |
LOINC Version: 2.77
FHIR